As of 2:50pm ET
| -0.03 / -1.55%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +318.85% increase from the last price of 1.91.
The current consensus among 1 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.